.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Covington
UBS
Teva
Cantor Fitzgerald
Chinese Patent Office
QuintilesIMS
Medtronic
Healthtrust
Baxter

Generated: November 21, 2017

DrugPatentWatch Database Preview

Ivax Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for IVAX PHARMS, and what generic and branded alternatives to IVAX PHARMS drugs are available?

IVAX PHARMS has forty-five approved drugs.



Summary for Ivax Pharms

US Patents:0
Tradenames:27
Ingredients:22
NDAs:45
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms
VALSARTAN
valsartan
TABLET;ORAL077530-001Jan 4, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
HYDROGENATED ERGOT ALKALOIDS
ergoloid mesylates
TABLET;SUBLINGUAL087185-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
CHLORTHALIDONE
chlorthalidone
TABLET;ORAL087947-001Feb 27, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25
hydralazine hydrochloride; hydrochlorothiazide
CAPSULE;ORAL088356-001Apr 10, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
FLUTEX
triamcinolone acetonide
OINTMENT;TOPICAL087375-001Nov 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
TABLET;ORAL085612-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL087004-002May 24, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET;ORAL085553-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
TRIFLUOPERAZINE HYDROCHLORIDE
trifluoperazine hydrochloride
TABLET;ORAL087612-001Nov 19, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
TRIFLUOPERAZINE HYDROCHLORIDE
trifluoperazine hydrochloride
TABLET;ORAL087328-001Nov 19, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Accenture
QuintilesIMS
Boehringer Ingelheim
Merck
Citi
US Department of Justice
Daiichi Sankyo
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot